Real-world implementation of the INDICAID COVID-19 rapid antigen test

Because the COVID-19 pandemic progresses, there may be an growing want for speedy, accessible assays for SARS-CoV-2 detection. We current a medical analysis and real-world implementation of the INDICAID COVID-19 speedy antigen take a look at (INDICAID speedy take a look at). A multisite medical analysis of the INDICAID speedy take a look at utilizing prospectively collected nasal (bilateral anterior) swab samples from symptomatic topics was carried out.

 

The INDICAID speedy take a look at demonstrated a optimistic % settlement (PPA) and damaging % settlement (NPA) of 85.3% (95% confidence interval [95% CI], 75.6% to 91.6%) and 94.9% (95% CI, 91.6% to 96.9%), respectively, in comparison with laboratory-based reverse transcriptase PCR (RT-PCR) utilizing nasal specimens.

The INDICAID speedy take a look at was then carried out at COVID-19 outbreak screening facilities in Hong Kong as a part of a testing algorithm (termed “dual-track”) to display asymptomatic people for prioritization for confirmatory RT-PCR testing. In a single method, preliminary optimistic INDICAID speedy take a look at outcomes triggered expedited processing for laboratory-based RT-PCR, decreasing the common time to confirmatory end result from 10.85 h to 7.Zero h. In a second method, preliminary optimistic outcomes triggered subsequent testing with an onsite speedy RT-PCR, decreasing the common time to confirmatory end result to 0.84 h.

In 22,994 asymptomatic sufferers, the INDICAID speedy take a look at demonstrated a PPA of 84.2% (95% CI, 69.6% to 92.6%) and an NPA of 99.9% (95% CI, 99.9% to 100%) in comparison with laboratory-based RT-PCR utilizing mixed nasal/oropharyngeal specimens. The INDICAID speedy take a look at has glorious efficiency in comparison with laboratory-based RT-PCR testing and, when utilized in tandem with RT-PCR, reduces the time to confirmatory optimistic end result.

click to read: Human Lactate Dehydrogenase A (LDHA) Protein | abx067672

INDICAID COVID-19 speedy antigen take a look at

IMPORTANCE Laboratory-based RT-PCR, the present gold customary for COVID-19 testing, can require a turnaround time of 24 to 48 h from pattern assortment to end result.

The delayed time to end result limits the effectiveness of centralized RT-PCR testing to cut back transmission and stem potential outbreaks. To deal with this, we performed an intensive analysis of the INDICAID COVID-19 speedy antigen take a look at, a 20-minute speedy antigen take a look at, in each symptomatic and asymptomatic populations. The INDICAID speedy take a look at demonstrated excessive sensitivity and specificity with RT-PCR because the comparator methodology.

A dual-track testing algorithm was additionally evaluated using the INDICAID speedy take a look at to display for preliminary optimistic sufferers, whose samples have been then prioritized for RT-PCR testing. The twin-track methodology demonstrated vital enhancements in expediting the reporting of optimistic RT-PCR take a look at outcomes in comparison with customary RT-PCR testing with out prioritization, providing an improved technique for neighborhood testing and controlling SARS-CoV-2 outbreaks.

H.pylori Antigen Rapid Test

IHP-N601 Hangzhou AllTest Biotech 1 kit Ask for price

H.pylori Antigen Rapid Test

IHP-N602 Hangzhou AllTest Biotech 1 kit Ask for price

COVID-19 Antigen Rapid Test

ICOV-802H Hangzhou AllTest Biotech 25 Tests 12.5 EUR

Brucella Antigen Rapid Test Kit

abx092116-100l Abbexa 100 µl 350 EUR

Brucella Antigen Rapid Test Kit

abx092116-1ml Abbexa 1 ml Ask for price

Brucella Antigen Rapid Test Kit

abx092116-200l Abbexa 200 µl Ask for price

S. pneumoniae Antigen Rapid Test

ISP-N102 Hangzhou AllTest Biotech 1 kit Ask for price

Norovirus Antigen Rapid Test Kit

abx092261-100l Abbexa 100 µl 1925 EUR

Norovirus Antigen Rapid Test Kit

abx092261-1ml Abbexa 1 ml 26250 EUR

Norovirus Antigen Rapid Test Kit

abx092261-200l Abbexa 200 µl 6600 EUR

Rotavirus Antigen Rapid Test Kit

abx092272-100l Abbexa 100 µl 362.5 EUR

Rotavirus Antigen Rapid Test Kit

abx092272-1ml Abbexa 1 ml Ask for price

Rotavirus Antigen Rapid Test Kit

abx092272-200l Abbexa 200 µl Ask for price

Rotavirus Antigen Rapid Test Kit

abx092133-100l Abbexa 100 µl 362.5 EUR

Rotavirus Antigen Rapid Test Kit

abx092133-1ml Abbexa 1 ml Ask for price

Rotavirus Antigen Rapid Test Kit

abx092133-200l Abbexa 200 µl Ask for price

Brucella antigen rapid test card

LSY-20076-2 Shenzhen Lvshiyuan Biotechnology 40 test/kit Ask for price

Toxoplasma Antigen Rapid Test Card

C11352 Ring Biotechnology Co 15T Ask for price

Salmonella typhi Antigen Rapid Test

ISTY-N602 Hangzhou AllTest Biotech 1 kit Ask for price

CPV&CCoV Antigen Rapid Test Card

C11611 Ring Biotechnology Co 10T Ask for price

SARS-CoV-2 Antigen Rapid Test

INCP-502H Hangzhou AllTest Biotech 25 Tests 8.75 EUR

Dog rabies Antigen rapid test card

LSY-20063 Shenzhen Lvshiyuan Biotechnology 10 test/kit Ask for price

Rabies Virus Antigen Rapid Test Kit

abx092033-100l Abbexa 100 µl 375 EUR

Rabies Virus Antigen Rapid Test Kit

abx092033-1ml Abbexa 1 ml Ask for price

Rabies Virus Antigen Rapid Test Kit

abx092033-200l Abbexa 200 µl Ask for price

Human Rotavirus Antigen Rapid Test Kit

abx472030-1096tests Abbexa 10 × 96 tests Ask for price

Human Rotavirus Antigen Rapid Test Kit

abx472030-596tests Abbexa 5 × 96 tests Ask for price

Human Rotavirus Antigen Rapid Test Kit

abx472030-96tests Abbexa 96 tests 237.5 EUR

Dog Toxoplasmosis Antigen Rapid Test Kit

abx092277-100l Abbexa 100 µl 362.5 EUR

Dog Toxoplasmosis Antigen Rapid Test Kit

abx092277-1ml Abbexa 1 ml Ask for price

The Efficiency of Two Speedy Antigen Checks Throughout Inhabitants-Degree Screening for SARS-CoV-2 An infection

 SARS-CoV-2 antigen assays supply a speedy imply to diagnose and isolate contaminated people. Nonetheless, their utility in population-level screening is unknown.
Aims: The efficiency of two antigen exams in detecting SARS-CoV-2 was assessed amongst people randomly chosen in the neighborhood.
 Examine Design: A potential examine that carried out head-to-head comparability of two SARS-CoV-2 antigen assays. People have been recruited throughout neighborhood SARS-CoV-2 screening over 10 working days. Demographic and medical knowledge have been collected. Normal Q COVID-19 Ag take a look at, a point-of-care chromatographic assay, was performed instantly, after which the pattern was transported to the virology laboratory to carry out PCR and the LIAISON SARS-CoV-2 Ag chemiluminesence immunoassay.
 Outcomes: respiratory samples from 991 people have been collected, and 62 have been optimistic by PCR. Inconclusive PCR outcomes have been noticed in 19 samples and have been excluded. The median age of individuals was 40.2 years (IQR 32.3-47.8), and 932 (94%) have been males. Most (77.4%) of infections have been asymptomatic. The sensitivity and the specificity of the LIAISON assay have been 43.3% (95%CI 30.6-56.8) and 99.9% (95%CI 99.3-100). The Normal Q assay had decrease sensitivity (30.6%, 95%CI 19.6-43.7) however related specificity (98.8%, 95%CI, 97.8-99.4). Equally, the LIAISON assay had larger optimistic predictive worth (96.3%, 95%CI 81-99.9% vs. 63.3%, 95%CI, 43.9-80.1%). Each assays carried out higher in symptomatic sufferers and amongst samples with a low-cycle threshold (Ct < 25).
Conclusion: In our setting of random neighborhood surveillance, speedy antigen testing of nasopharyngeal swabs by both LIAISON SARS-CoV-2 Ag (DiaSorin) or Normal Q COVID-19 Ag (SD Biosensor) was much less delicate to detecting SARS-CoV-2 than the TaqPath COVID-19 RT-PCR.
By Mashid

Leave a Reply

Your email address will not be published. Required fields are marked *

No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.